KLF9 and hepatocellular carcinoma: Moreover, the upregulation of KLF9 inhibits the proliferation and migration of HCC cells and induces apoptosis [35], and its ectopic expression delays the onset of HCC tumors and promotes the regression of established tumors in vivo [36].